These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 7879034

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Anti-CD2 monoclonal antibodies synergize with anti-CD3 to prolong allograft survival and decrease cytokine production.
    Chavin KD, Qin L, Lin J, Kaplan AJ, Bromberg JS.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):823-4. PubMed ID: 8094913
    [No Abstract] [Full Text] [Related]

  • 5. A rat anti-mouse CD3 monoclonal antibody induces long-term skin allograft survival without inducing side effects.
    Vossen AC, Tibbe GJ, van Oudenaren A, Vredendaal AE, Benner R, Savelkoul HF.
    Transplant Proc; 1994 Dec; 26(6):3157-8. PubMed ID: 7998101
    [No Abstract] [Full Text] [Related]

  • 6. Anti-CD4 monoclonal antibody-induced allograft survival is associated with a defect in interleukin-2-dependent T-cell activation.
    Pearson TC, Hamano K, Morris PJ, Wood KJ.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):786-7. PubMed ID: 8438480
    [No Abstract] [Full Text] [Related]

  • 7. Prolongation of murine cardiac allograft survival by the anti-interleukin-2 receptor monoclonal antibody AMT-13.
    Kirkman RL, Barrett LV, Koltun WA, Diamantstein T.
    Transplant Proc; 1987 Feb; 19(1 Pt 1):618-9. PubMed ID: 3274828
    [No Abstract] [Full Text] [Related]

  • 8. Stability of tolerance in mice generated by CD4 and CD8 monoclonal antibody treatment: cell transfer experiments.
    Chen Z, Cobbold S, Waldmann H, Metcalfe S.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):790-1. PubMed ID: 8438482
    [No Abstract] [Full Text] [Related]

  • 9. Immunosuppression by aminopterin or idarubicin conjugated to anti-CD8 in the mouse heart allograft model.
    Mottram PL, Pietersz GA, Purcell LJ, Krauer K, McKenzie IF.
    Transplant Proc; 1992 Oct; 24(5):2301. PubMed ID: 1413068
    [No Abstract] [Full Text] [Related]

  • 10. A non-lymphocyte-depleting monoclonal antibody to the adhesion molecule LFA-1 (CD11a) prevents sensitization to alloantigens and effectively prolongs the survival of heart allografts.
    Nakakura EK, McCabe SM, Zheng B, Shorthouse RA, Scheiner TM, Blank G, Jardieu PM, Morris RE.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):809-12. PubMed ID: 8438493
    [No Abstract] [Full Text] [Related]

  • 11. Prolongation in murine cardiac allograft survival with monoclonal antibodies to LFA-1, ICAM-1, and CD4.
    Jendrisak M, Jendrisak G, Gamero J, Mohanakumar T.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):825-7. PubMed ID: 8094914
    [No Abstract] [Full Text] [Related]

  • 12. Effects of exogenous IL-2 on tolerance induction by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies.
    Isobe M, Suzuki J, Yamazaki S, Sekiguchi M.
    Transplant Proc; 1996 Apr; 28(2):1045-6. PubMed ID: 8623222
    [No Abstract] [Full Text] [Related]

  • 13. Immunologic characterization of murine cardiac allograft recipients with long-term graft survival due to anti-VCAM-1 or anti-CD4 monoclonal antibody therapy.
    Orosz CG, Bergese SD, Huang EH, Vanbuskirk AM.
    Transplant Proc; 1995 Feb; 27(1):387-8. PubMed ID: 7533414
    [No Abstract] [Full Text] [Related]

  • 14. Tolerance induction against cardiac allograft by anti-ICAM-1 and anti-LFA-1 treatment: T cells respond to in vitro allostimulation.
    Isobe M, Ihara A.
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1079-80. PubMed ID: 8095106
    [No Abstract] [Full Text] [Related]

  • 15. Low-dose anti-CD3 therapy provides long-term graft survival in a Lewis rat to C57BL/6 xeno-islet transplantation model.
    Jeyarajah DR, Schmeisser FS, Josephson MA, Sohn DG, Thistlethwaite JR.
    Transplant Proc; 1994 Apr; 26(2):771-3. PubMed ID: 8171656
    [No Abstract] [Full Text] [Related]

  • 16. Monoclonal antibody to anti-VCAM-1 interferes with murine cardiac allograft rejection.
    Pelletier R, Ohye R, Kincade P, Ferguson R, Orosz C.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):839-41. PubMed ID: 7679845
    [No Abstract] [Full Text] [Related]

  • 17. Combined anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donor-specific tolerance in a cardiac transplant model.
    Chavin KD, Qin L, Lin J, Yagita H, Bromberg JS.
    J Immunol; 1993 Dec 15; 151(12):7249-59. PubMed ID: 7903105
    [Abstract] [Full Text] [Related]

  • 18. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
    Cai Y, Tang XD, Zhou PJ.
    Scand J Immunol; 2005 Mar 15; 61(3):266-73. PubMed ID: 15787744
    [Abstract] [Full Text] [Related]

  • 19. Prevention and reversal of renal allograft rejection by monoclonal antibody to CD45RB in the mouse model.
    Zhang Z, Zhong R, Grant D, Garcia B, White M, Stiller C, Lazarovits A.
    Transplant Proc; 1995 Feb 15; 27(1):389. PubMed ID: 7879031
    [No Abstract] [Full Text] [Related]

  • 20. Comparative immunosuppressive effect of anti-CD18 and anti-CD11a monoclonal antibodies on rat heart allotransplantation.
    Kameoka H, Ishibashi M, Tamatani T, Takano Y, Moutabarrik A, Jiang H, Kokado Y, Takahara S, Miyasaka M, Okuyama A.
    Transplant Proc; 1993 Feb 15; 25(1 Pt 1):833-6. PubMed ID: 8094917
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.